BioCentury
ARTICLE | Financial News

Aldeyra raises $25 million in follow-on

September 19, 2017 7:05 PM UTC

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) raised $25 million through the sale of 3.5 million shares at $7.25 in a follow-on underwritten by Cantor Fitzgerald and Laidlaw. The price is a 20% discount to Aldeyra’s close of $9.10 on Monday when it proposed the offering after market hours.

Aldeyra was down $1.85 (20%) to $7.25 on Tuesday...

BCIQ Company Profiles

Aldeyra Therapeutics Inc.